Prospective Study
Copyright ©The Author(s) 2025.
World J Clin Pediatr. Mar 9, 2025; 14(1): 100453
Published online Mar 9, 2025. doi: 10.5409/wjcp.v14.i1.100453
Table 1 Univariate analysis of clinical and laboratory parameters in those with and without cardiac involvement, n (%)
Clinical parameters
With cardiac involvement (n = 211)
Without cardiac involvement (n = 59)
Odds ratio (95%CI)
P value
Gender (female)94 (78)26 (21.6)0.98 (0.52-1.82)0.534
Pain abdomen103 (48.80)29 (49.97) 0.986 (0.55-1.766)0.54
Altered sensorium78 (36.97)12 (20.34)2.29 (1.164-4.745)0.010
Breathlessness64 (30.3)4 (6.78)5.95 (2.231-20.06)< 0.001
Cracked lips94 (44.55)21 (35.59)1.45 (0.800-2.676)0.139
Diarrhea195 (77.21)31 (52.54)0.895 (0.499-1.600)0.409
Edema100 (47.39)17 (28.81)2.22 (1.197-4.232)0.007
Fever (> 38 °C)209 (99.0)56 (94.92)5.55 (0.622-67.95)0.071
Oliguria43 (20.38) 5 (2.47)2.75 (1.019-9.36)0.022
Rash97 (45.97)33 (55.93)0.671 (0.358-1.247)0.113
Red eye129 (61.14)36 (61.02)1.005 (0.55-1.815)0.55
Red lips80 (37.91)22 (37.29)1.02 (0.56-1.88)0.528
Vomiting161 (76.3)45 (76.27)1.008 (0.49-1.95)0.559
Non-rebreathing mask96 (45.71)0Undefined< 0.001
Hi-flow nasal cannula51 (24.17)1 (1.92)18.3 (3.4-382.5)< 0.001
Bilevel positive airway pressure16 (7.88)1 (1.69)4.94 (0.86-106.8)0.07
Invasive ventilation 53 (25.24)0Undefined0.001
Thrombocytopenia108 (51.18)14 (24.14)3.28 (1.711-6.52)< 0.001
Thrombocytosis62 (29.52)17 (28.81)1.03 (0.55-1.994)0.527
Anemia128 (60.66)11 (28.81)3.79 (2.04-7.248)< 0.001
Hyponatremia170 (80.59)36 (61.01)2.638 (1.401-4.938)0.002
Continuous variables
Age (years)6 (2-9)5 (2.5-9)0.912
Heart rate/minute130 (112-150)110 (100-130) < 0.001
C-reactive protein (mg/L)48 (12-112)_48 (12-137)0.785
Erythrocyte sedimentation rate (mm/hour)45 (28-80)49.5 (31-88)0.49
Highest platelet count (103/L)294 (178-486)343 (215-502) 0.132
Lowest platelet count (103/L)127 (65-225)250 (120-320)0.001
Neutrophil-to-lymphocyte ratio4 (2.2.-8)3 (2-5.3)0.150
White blood cell count (103/L)15.65 (11-21.6)12.4 (8.9- 17.2)0.004
Aspartate aminotransferase (U/L) 41 (26-90)31 (24-53)0.047
Alanine aminotransferase (U/L)32 (18-66)25 (14-47)0.042
Urea (mg/dL)31.5 (21-54_21 (16.5-27.5)0.001
Creatinine (mg/dL)0.4 (0.3-0.6)0.4 (0.3-0.5)0.087
Ejection fraction58 (48-62)63 (60-66)< 0.001
Fractional shortening 31 (26-33)33.5 (33-35)0.017
interleukin-6 (pg/mL) (n = 95)187.6 (19.2-32029.9 (9.36-142)0.08
D-dimer (mg/L) (n = 125)13.1 (1.57-5.1)1.83 (0,88-3.29)0.028
Procalcitonin (ng/mL) (n = 70)115.8 (2.2-44.5)0.76 (0.25-5.62)0.014
Troponin I (ng/mL) (n = 49)118.6 (0.01-141.8)0.01-
N-terminal pro-brain natriuretic peptide (pg/mL) (n = 49)14875 (559-16006)26-
Ferritin (ng/mL) (n = 166)1575 (293-1335)281 (254-576)0.001
Coronavirus disease 2019 antibody titre63.8 (24.8-95)65.8 (23.5-102.4)0.58
Hospital stay (days)10 (7-13)8 (7-11)0.070
Prehospital illness (days)5 (3-7)5 (4-7)0.333